Navigation Links
FDA Approved Treatment for Painful Intercourse (Dyspareunia) Due to Menopause
Date:2/27/2013

us Thromboembolism: In the WHI estrogen-alone substudy, the risk of VTE (DVT and PE) was increased for women receiving CE 0.625 mg alone compared to placebo (30 vs. 22 per 10,000 women-years), although only increased risk of DVT reached statistical significance (23 vs. 15 per 10,000 women- years). The increase in VTE risk was demonstrated during the first 2 years. Incidence rate of DVT was 1.45 Osphena vs. 1.04 placebo per thousand women. Should a VTE occur or be suspected, Osphena should be discontinued immediately. Osphena should be discontinued at least 4 to 6 weeks before surgery with increased risk of thromboembolism or during periods of prolonged immobilization.

Malignant Neoplasms

Endometrial Cancer: There is an increased risk of endometrial cancer in a woman with a uterus who uses unopposed estrogen therapy. The risk appears dependent on duration of treatment and estrogen dose. Adding a progestin to estrogen therapy has been shown to reduce the risk of endometrial hyperplasia, which may be a precursor to endometrial cancer. However, studies suggest a possible increased risk for breast cancer in patients receiving estrogen plus progestin therapy.

  •     Osphena is an estrogen agonist/antagonist with tissue selective effects. In the endometrium Osphena has agonistic effects. In Osphena clinical trials, no cases of endometrial cancer were seen with exposure up to 52 weeks. There was a single case of simple hyperplasia without atypia. Endometrial thickening equal to 5mm or greater was reported at a rate of 60.1 Osphena vs. 21.2 placebo per 1000 women. Uterine polyps occurred at an incidence of 5.9 Osphena vs. 1.8 placebo per 1000 women, and any type of proliferative endometrium (weakly plus active plus disordered) was 86.1 Osphena vs. 13.3 placebo per 1000 women.
  •     Adequate diagnostic measures, including directed or random endometrial sampling when indicat
    '/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. ASHA Approved Continuing Education Provider HomeCEUConnection.com Announces Two New Live, Interactive Webinars for California Speech-Language Pathologists.
2. EzW2Correction Software Was Approved By SSA To Print W-2C and W-3C On White Paper
3. Newly approved oral medication slows rheumatoid arthritis joint damage
4. Westbridge Agricultural Products Announces that Botector® has been EPA Approved as an Organic Biopesticide to Prevent Gray Mold in Grapes
5. First FDA approved subcutaneous implantable defibrillator available for patients
6. Not all lung cancer patients who could benefit from crizotinib are identified by FDA-approved test
7. Moffitt Cancer Center melanoma expert reviews unique adverse events with newly approved drug
8. AGA releases first independently developed ABIM-approved Practice Improvement Module in GI
9. Mayo Clinic offers newly approved treatment for acid reflux disease
10. Experimental Vitiligo Treatment Shows Promise in Mice
11. DNDi receives BBVA Foundation award for delivering new treatments for neglected diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015 The New Mel Brooks Musical ... will be performed by the award-winning Drama Department of ... March 6-22, 2015, on Fridays, Saturdays and Sundays. Performances ... School (27118 Silver Spur Road, Rolling Hills Estates, ... program or may be purchased on-line at https://sites.google.com/site/penhidrama ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Columbus is no ... steady prevalence of cocaine addiction, and suffers from the ... on Feb. 27th, the DEA revealed that Kratom is ... a herbal tea; the newly introduced herb from Southeast Asia ... in heightened doses. WKYC notes kratom foments symptoms similar to ...
(Date:3/4/2015)... 2015 The Alliance for Regenerative ... its upcoming fifth annual Advanced Therapies Summit next ... event this year will feature five expert-led interactive ... the field’s leading companies and organizations. , ... and clinical researchers from the advanced therapies community ...
(Date:3/4/2015)... Today Visiopharm announces that Patrik Dahlén, previously ... Visiopharm Board of Directors as Chairman. ... are positioned to become the fastest growing software company, ... research. , "Over the last several years, ... of ONCOtopix™ Dx, a complete quantitative digital pathology solution ...
(Date:3/4/2015)... Follow us on LinkedIn – ... increasing incidence of CNS disorders, aging population, rising healthcare ... The unmet medical needs for diagnosing and treating CNS ... market. Presently, there exists an urgent need for developing ... current generation drugs. Companies are therefore investing to develop ...
Breaking Medicine News(10 mins):Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2Health News:Columbus, OH Combats the Sale of Kratom as a Drug, Harbor Village Detox Stresses Caution 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 3Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 2Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 4
... Patients with a specific kind of lung cancer may benefit ... UCSD Cancer Center. The new drug, crizotinib, under development by ... some patients during Phase I and II clinical trials. ... encouraging," said Lyudmila Bazhenova, MD, assistant clinical professor at UC ...
... ... RE/MAX agent who participates in the “Home for the Cure™” program, through ... for the Cure when a home sale is complete. The newly rebranded ... signs, is meant to raise money for breast cancer research, education and ...
... St. Gregory Retreat ... Health Program. , ... 22, 2010 -- St Gregory Centers, Inc. announced today that they have signed agreements with ... employees. The Mayo Clinic program will be an integral part of St Gregory’s Life ...
... to be published on 21 June 2010 in the ... (Inserm unit 625 Research Group on Human and ... Hospital Centre) in Pointe Pitre (urology department, University ... the Center for Analytical Research and Technology (University of ...
... Researchers at the Oregon Health & Science University ... bioluminescence a way of measuring visible light generated from ... rapidly assessing in children at the chair-side the number of ... to tooth decay. The study is published ...
... ... to young women. They promote thinness at all costs and often disregard ... Journal of Public Health published a recent study of Pro Ana websites. This ... Stanford University School of Medicine, has raised questions about how we can meet ...
Cached Medicine News:Health News:Susan G. Komen for the Cure and RE/MAX Launch Home for the Cure™ 2Health News:Susan G. Komen for the Cure and RE/MAX Launch Home for the Cure™ 3Health News:Susan G. Komen for the Cure and RE/MAX Launch Home for the Cure™ 4Health News:St. Gregory Centers, Inc. Announces Integrating Mayo Clinic Health Wellness Program 2Health News:Chlordecone exposure and risk of prostate cancer 2Health News:OHSU School of Dentistry team examines how to rapily assess children's tooth decay risk 2Health News:Pro Ana Versus Pro Recovery Sites: New Study by Johns Hopkins and Stanford University raises concerns. 2Health News:Pro Ana Versus Pro Recovery Sites: New Study by Johns Hopkins and Stanford University raises concerns. 3
(Date:3/4/2015)... 4, 2015   Mallinckrodt plc (NYSE: ... present at the Barclays Global Healthcare Conference at the ... , on Wednesday, March 11, 2015. Mark Trudeau, President and ... in a session scheduled to begin at 10:45 a.m. ... in person can find webcast information on Mallinckrodt,s ...
(Date:3/4/2015)...  ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) announced ... Conference at the Ritz-Carlton at Laguna Niguel, California ... Arthur S. Przybyl , President and CEO, will give ... of ANI,s website at www.anipharmaceuticals.com . Mr. Przybyl,s presentation ... and available through the link through June 7, 2015. ...
(Date:3/3/2015)... JACKSONVILLE, Fla. , March 3, 2015 /PRNewswire/ ... is pleased to announce the hiring of ... Sales to lead business development efforts and build ... years of experience in software development, sales, and ... of enterprise software applications. iTraycer is a comprehensive ...
Breaking Medicine Technology:Mallinckrodt to Present at Barclays Conference March 11 2ANI Pharmaceuticals To Present At 27th Annual ROTH Conference 2Medical Tracking Solutions, Inc. Hires New SVP, Sales 2
... 27, 2011 A milestone in lupus research was met this ... Research (ALR) held its 8th annual New York City Walk ... Park was matched by the enthusiasm of the nearly 3000 walkers ... by NYC master of ceremonies, My9 news anchor Brenda Blackmon, ALR ...
... 27, 2011   FHSSA counts its partnership initiative ... known as the Foundation for Hospices in Sub-Saharan ... between US hospice programs and organizations providing care ... assistance, support and friendship.  They are working collaboratively ...
Cached Medicine Technology:Alliance for Lupus NYC Walk With Us to Cure Lupus First Lupus Walk In History To Raise $1-Million 2FHSSA Launches New Campaign to Partner US Hospices with Programs in Sub-Saharan Africa 2
Microsurgical straight forceps made of titanium has straight shafts with smooth working surface. TCI working parts 6 mm from tips with round handle, diam. 6 mm, overall length 116 mm....
Curved tying forceps made of titanium has curved shafts with 6 mm V-grove tying platforms, width of shafts 0,5 mm, TCI platforms, flat handle, width 10 mm, overall length 103 mm....
Curved tying spring forceps made of titanium, delicate smooth jaws, length 10 mm, TCI jaws with round handle, diam. 8 mm and overall length 115 mm....
Thornton titanium curved suture tying forceps, 4"....
Medicine Products: